Newsbenzinga
Acurx Pharmaceuticals Says First Patient Enrolled In New PATHFINDER Clinical Trial In Patients With Multiply Recurrent C. Difficile Infection
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…